UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 29

of 'The role of local therapies in metastatic breast cancer'

29
TI
Radiofrequency ablation in the management of liver metastases from breast cancer.
AU
Sofocleous CT, Nascimento RG, Gonen M, Theodoulou M, Covey AM, Brody LA, Solomon SM, Thornton R, Fong Y, Getrajdman GI, Brown KT
SO
AJR Am J Roentgenol. 2007;189(4):883.
 
OBJECTIVE: Systemic chemotherapy remains the standard treatment for patients with breast cancer hepatic metastases. Resection of metastases has survival advantages in a small percentage of selected patients. Radiofrequency ablation has been used in small numbers of selected patients. This small series was undertaken to review our experience with radiofrequency ablation in the management of patients with breast cancer hepatic metastases.
CONCLUSION: Radiofrequency ablation of breast cancer hepatic metastases is safe and may be used to control hepatic deposits in patients with stable or no extrahepatic disease.
AD
Section of Interventional Radiology and Image Guided Therapies, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., Rm. H118, New York, NY 10021, USA. sofoclec@mskcc.org
PMID